biotech / news / / Newsweek
Claims that COVID‑19 vaccine maker Moderna is developing an mRNA vaccine for hantavirus are circulating on social media.
Moderna is only providing mRNA materials and technical support to Korea University's hantavirus project.
KEY POINTS
- The vaccine under development targets Asian hantavirus strains causing Hemorrhagic Fever with Renal Syndrome, not U.S. strains.
- There is no U.S. vaccination program or approved Moderna hantavirus vaccine initiative underway.
- Moderna’s vaccine research is unrelated to the Andes hantavirus outbreak on the Dutch cruise ship.
COMPANIES
Summarized by Newsio from Newsweek. How we summarize →